Venu
Position Trader, Market Leaders, Fundamental/Technical Analysis
Teradyne shows leadership character in two of the hottest themes, semiconductor testing and robotics: it has posted back-to-back strong earnings and every dip to its 50-day moving average gets bought. It also leads industrial automation through Universal Robots and MiR, helping factories automate repetitive, high-precision, labor-heavy tasks. x.comÂ
Teradyne is trying to push off its 200 EMA and support zone after a stellar Q2. Adjusted EPS was $2.47 versus $2.09 expected and sales $1.329B versus $1.223B, and it raised Q3 EPS and sales guidance. x.comÂ
Teradyne supplies the testing behind the AI revolution, with fundamentals accelerating and technicals confirming. x.comÂ
Teradyne's Q2 outlook coming in below its Q1 results is concerning when demand should be sky-high, and if later quarters look the same, its P/E would be too high to justify buying. x.comÂ
Teradyne is a multiyear compounder as both the cobot layer of factory automation and the test layer for AI chips. Its Universal Robots unit makes collaborative robots that let factories retrofit a line in a weekend instead of a year, and it is the spine of half the factory floors automating in 2026. Its semiconductor test gear is what every AI chip passes through, its own or Advantest's. Forward EPS of $9.51 at 35x anchors fair value at $333, near the current $337.88; the 320s would be a buy. … Show more
Teradyne is a solid core position for the broader semiconductor test theme because it is much more diversified than a concentrated wafer-level burn-in bet such as Aehr Test Systems. x.comÂ
Teradyne looks less dominant in CPO testing than expected after it acknowledged Advantest's capabilities on its earnings call. Per GF Securities, low TSMC SoIC yields have led the industry to cut 2026 CPO shipment forecasts, and Teradyne enters a 2H26 transition: Q2 guidance implies a 6% sequential drop, 55-60% of 2026 revenue falls in the first half, and it trades at 47x 2026 earnings. GF still sees long-term CPO upside, with 2027 CPO revenue possibly $800M. x.com x.comÂ
Teradyne is a high-quality AI infrastructure name with significant long-term upside, as a surge in free cash flow has left it debt-free and tracking toward about $600 million a year. The price target remains $435 by mid-2027. The latest earnings were not flawless: limited visibility and potential lumpiness in the second half of 2026 create substantial uncertainty that will overhang the stock. x.comÂ
Teradyne's test business is surging because rising AI chip complexity multiplies testing demand. Q2 revenue was a record $1.329 billion, up about 104% and above consensus, and Semiconductor Test revenue rose 128% to $1.122 billion. Management said AI is now its primary growth engine, contributing about $1.2 billion of Q2 revenue across compute, HBM and networking. More sophisticated GPUs, ASICs and HBM need far more testing, making its high-end ATE mission-critical. x.comÂ
Teradyne's growth is slowing, undercutting the AI-test growth valuation that lifted shares 242% in 2025. Q1 revenue nearly doubled to $1.28 billion and EPS of $2.56 beat the $2.04 estimate, but Q2 guidance of $1.15-1.25 billion is nearly 10% lower at the midpoint, and gross margin falls to 58-59% as one-off gains fade. Merchant GPU test revenue is only about $50 million this year against Advantest's entrenched lead, and about 70% AI exposure with concentrated customers magnifies tariff risk. … Show more
Advantest proved it deserves a premium valuation: its SoC tester market share rose from 56% in 2024 to 66% in 2025, widening its lead over Teradyne. It also received its first high-volume ATE order for silicon photonics. x.comÂ
